Please Wait
Applying Filters...
menu
    • menu
    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Axitinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 47,975Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Apotex’s Generics Axitinib Receives Approval in US
    Apotex’s Generics Axitinib Receives Approval in US

    30 Oct 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211650

    FDA
    30 Oct 2025
    Share Share
    Apotex’s Receives First Generic Approval for Axitinib in US
    Apotex’s Receives First Generic Approval for Axitinib in US

    30 Oct 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=211650

    FDA
    30 Oct 2025
    Share Share
    HUTCHMED to Present FRUSICA-2 Trial Data at ESMO 2025
    HUTCHMED to Present FRUSICA-2 Trial Data at ESMO 2025

    13 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/13/3165267/0/en/HUTCHMED-Highlights-FRUSICA-2-Registration-Trial-Data-to-be-Presented-at-the-2025-ESMO-Congress.html

    GLOBENEWSWIRE
    13 Oct 2025
    Share Share
    Sandoz’s Generics Axitinib Receives Tentative Approval In US
    Sandoz’s Generics Axitinib Receives Tentative Approval In US

    07 Oct 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219705

    FDA
    07 Oct 2025
    Share Share
    Glenmark’s Generics Axitinib Receives Tentative Approval in US
    Glenmark’s Generics Axitinib Receives Tentative Approval in US

    21 Jul 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213235

    FDA
    21 Jul 2025
    Share Share
    Ocular Therapeutix Accelerated Timelines For SOL-1 Trial In Wet AMD
    Ocular Therapeutix Accelerated Timelines For SOL-1 Trial In Wet AMD

    15 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/15/2963077/0/en/Ocular-Therapeutix-Announces-Accelerated-Timelines-for-SOL-1-Registrational-Trial-of-AXPAXLI-in-Wet-AMD.html

    GLOBENEWSWIRE
    15 Oct 2024
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.